Nomura Asset Management Co. Ltd. Sells 4,693 Shares of Humana Inc. (NYSE:HUM)

Nomura Asset Management Co. Ltd. decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 11.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,673 shares of the insurance provider’s stock after selling 4,693 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Humana were worth $9,304,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank bought a new position in shares of Humana during the 4th quarter worth about $416,202,000. Pzena Investment Management LLC raised its position in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after buying an additional 1,103,132 shares during the last quarter. Boston Partners lifted its stake in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after buying an additional 893,637 shares during the period. Finally, Artisan Partners Limited Partnership grew its position in Humana by 83.4% during the fourth quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock worth $170,928,000 after buying an additional 306,433 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the company. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Finally, Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Price Performance

Shares of HUM stock opened at $264.35 on Tuesday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm’s 50 day moving average is $269.77 and its 200-day moving average is $273.07. The firm has a market capitalization of $31.91 billion, a price-to-earnings ratio of 26.57, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana’s dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.